Literature DB >> 20541149

46,XX DSD: the masculinised female.

Richard J Auchus1, Alice Y Chang.   

Abstract

The 46,XX disorders of sex development (DSDs) cause virilisation or masculinisation of the female foetus. The final common pathway of all 46,XX DSDs is excess dihydrotestosterone (DHT) or potent foreign androgen in the genital tissue during the critical period of sexual differentiation. Whereas the foetal testis is source of androgen in the male, it is the foetal adrenal that produces the DHT precursors in the female. By understanding the principles of human steroid biosynthesis, the pathogenesis of each disorder may be logically deduced, and treatment strategies are rationally constructed. In practice, however, therapies for many of these diseases are fraught with complications and caveats, and current approaches leave much room for improvement. This review discusses these diseases, their pathogenesis and approaches to therapy. We emphasise areas where improved treatments are sorely needed. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541149     DOI: 10.1016/j.beem.2009.11.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  4 in total

Review 1.  Azole Fungicides and Their Endocrine Disrupting Properties: Perspectives on Sex Hormone-Dependent Reproductive Development.

Authors:  Monica Kam Draskau; Terje Svingen
Journal:  Front Toxicol       Date:  2022-04-28

Review 2.  Disorders of Sex Development of Adrenal Origin.

Authors:  Gabriela P Finkielstain; Ana Vieites; Ignacio Bergadá; Rodolfo A Rey
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-20       Impact factor: 5.555

3.  Cohort profile: pathways to care among people with disorders of sex development (DSD).

Authors:  Michael Goodman; Rami Yacoub; Darios Getahun; Courtney E McCracken; Suma Vupputuri; Timothy L Lash; Douglas Roblin; Richard Contreras; Lee Cromwell; Melissa D Gardner; Trenton Hoffman; Haihong Hu; Theresa M Im; Radhika Prakash Asrani; Brandi Robinson; Fagen Xie; Rebecca Nash; Qi Zhang; Sadaf A Bhai; Kripa Venkatakrishnan; Bethany Stoller; Yijun Liu; Cricket Gullickson; Maaz Ahmed; David Rink; Ava Voss; Hye-Lee Jung; Jin Kim; Peter A Lee; David E Sandberg
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

4.  Clinically relevant genetic advances in endocrinology.

Authors:  Angela Rogers; Rajesh V Thakker
Journal:  Clin Med (Lond)       Date:  2013-06       Impact factor: 2.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.